{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:21:39Z","timestamp":1783732899028,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00406-017-0789-7","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T11:32:07Z","timestamp":1490355127000},"page":"781-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8414-0910","authenticated-orcid":false,"given":"Laura","family":"Kranaster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna Su","family":"Aksay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Malte","family":"Bumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Markus","family":"Leweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Janke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bindila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"789_CR1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","volume":"79","author":"HC Lu","year":"2016","unstructured":"Lu HC, Mackie K (2016) An introduction to the endogenous cannabinoid system. Biol Psychiatry 79:516\u2013525","journal-title":"Biol Psychiatry"},{"key":"789_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M Glass","year":"1997","unstructured":"Glass M, Dragunow M, Faull RL (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299\u2013318","journal-title":"Neuroscience"},{"key":"789_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1517\/14728222.10.2.203","volume":"10","author":"KY Vinod","year":"2006","unstructured":"Vinod KY, Hungund BL (2006) Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 10:203\u2013210","journal-title":"Expert Opin Ther Targets"},{"key":"789_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000337376","volume":"89","author":"B Kraft","year":"2012","unstructured":"Kraft B (2012) Is there any clinically relevant cannabinoid-induced analgesia? Pharmacology 89:237\u2013246","journal-title":"Pharmacology"},{"key":"789_CR5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 153:199\u2013215","journal-title":"Br J Pharmacol"},{"issue":"27","key":"789_CR6","doi-asserted-by":"crossref","first-page":"16865","DOI":"10.1074\/jbc.273.27.16865","volume":"273","author":"CS Breivogel","year":"1998","unstructured":"Breivogel CS, Selley DE, Childers SR (1998) Cannabinoid receptor agonist efficacy for stimulating [s-35]gtp-gamma-s binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem 273(27):16865\u201316873","journal-title":"J Biol Chem"},{"key":"789_CR7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","volume":"1074","author":"ES Onaivi","year":"2006","unstructured":"Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514\u2013536","journal-title":"Ann N Y Acad Sci"},{"key":"789_CR8","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","volume":"111","author":"HY Zhang","year":"2014","unstructured":"Zhang HY, Gao M, Liu QR, Bi GH, Li X, Yang HJ, Gardner EL, Wu J, Xi ZX (2014) Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc Natl Acad Sci USA 111:E5007\u2013E5015","journal-title":"Proc Natl Acad Sci USA"},{"key":"789_CR9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946\u20131949","journal-title":"Science"},{"key":"789_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161\u2013202","journal-title":"Pharmacol Rev"},{"key":"789_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89\u201397","journal-title":"Biochem Biophys Res Commun"},{"key":"789_CR12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","volume":"388","author":"N Stella","year":"1997","unstructured":"Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773\u2013778","journal-title":"Nature"},{"key":"789_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","volume":"16","author":"B Lutz","year":"2015","unstructured":"Lutz B, Marsicano G, Maldonado R, Hillard CJ (2015) The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci 16:705\u2013718","journal-title":"Nat Rev Neurosci"},{"key":"789_CR14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.biopsych.2015.11.018","volume":"79","author":"FM Leweke","year":"2016","unstructured":"Leweke FM, Mueller JK, Lange B, Rohleder C (2016) Therapeutic potential of cannabinoids in psychosis. Biol Psychiatry 79:604\u2013612","journal-title":"Biol Psychiatry"},{"key":"789_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","volume":"16","author":"LH Parsons","year":"2015","unstructured":"Parsons LH, Hurd YL (2015) Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci 16:579\u2013594","journal-title":"Nat Rev Neurosci"},{"key":"789_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/JCP.0000000000000581","volume":"36","author":"MA Katzman","year":"2016","unstructured":"Katzman MA, Furtado M, Anand L (2016) Targeting the endocannabinoid system in psychiatric illness. J Clin Psychopharmacol 36:691\u2013703","journal-title":"J Clin Psychopharmacol"},{"key":"789_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","volume":"138","author":"V Micale","year":"2013","unstructured":"Micale V, Di Marzo V, Sulcova A, Wotjak CT, Drago F (2013) Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther 138:18\u201337","journal-title":"Pharmacol Ther"},{"key":"789_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1745-0179-3-25","volume":"3","author":"G Serra","year":"2007","unstructured":"Serra G, Fratta W (2007) A possible role for the endocannabinoid system in the neurobiology of depression. Clin Pract Epidemiol Mental Health 3:25","journal-title":"Clin Pract Epidemiol Mental Health"},{"key":"789_CR19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.2009.369","volume":"301","author":"MN Hill","year":"2009","unstructured":"Hill MN, Gorzalka BB (2009) Impairments in endocannabinoid signaling and depressive illness. JAMA 301:1165\u20131166","journal-title":"JAMA"},{"key":"789_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.06.007","volume":"42","author":"MS Crowe","year":"2014","unstructured":"Crowe MS, Nass SR, Gabella KM, Kinsey SG (2014) The endocannabinoid system modulates stress, emotionality, and inflammation. Brain Behav Immun 42:1\u20135","journal-title":"Brain Behav Immun"},{"key":"789_CR21","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.2174\/13816128113196660735","volume":"20","author":"CJ Hillard","year":"2014","unstructured":"Hillard CJ, Liu QS (2014) Endocannabinoid signaling in the etiology and treatment of major depressive illness. Curr Pharm Des 20:3795\u20133811","journal-title":"Curr Pharm Des"},{"key":"789_CR22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2174\/1570159X12666140923205412","volume":"12","author":"I Smaga","year":"2014","unstructured":"Smaga I, Bystrowska B, Gawlinski D, Przegalinski E, Filip M (2014) The endocannabinoid\/endovanilloid system and depression. Curr Neuropharmacol 12:462\u2013474","journal-title":"Curr Neuropharmacol"},{"key":"789_CR23","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.pnpbp.2010.11.021","volume":"35","author":"BB Gorzalka","year":"2011","unstructured":"Gorzalka BB, Hill MN (2011) Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. Prog Neuro Psychopharmacol Biol Psychiatry 35:1575\u20131585","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"789_CR24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12640-014-9465-0","volume":"26","author":"I Smaga","year":"2014","unstructured":"Smaga I, Bystrowska B, Gawlinski D, Pomierny B, Stankowicz P, Filip M (2014) Antidepressants and changes in concentration of endocannabinoids and n-acylethanolamines in rat brain structures. Neurotox Res 26:190\u2013206","journal-title":"Neurotox Res"},{"key":"789_CR25","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1523\/JNEUROSCI.0163-14.2014","volume":"34","author":"JI Wamsteeker Cusulin","year":"2014","unstructured":"Wamsteeker Cusulin JI, Senst L, Teskey GC, Bains JS (2014) Experience salience gates endocannabinoid signaling at hypothalamic synapses. J Neurosci 34:6177\u20136181","journal-title":"J Neurosci"},{"key":"789_CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2007.04713.x","volume":"103","author":"MN Hill","year":"2007","unstructured":"Hill MN, Barr AM, Ho WS, Carrier EJ, Gorzalka BB, Hillard CJ (2007) Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. J Neurochem 103:47\u201356","journal-title":"J Neurochem"},{"key":"789_CR27","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","volume":"29","author":"A Giuffrida","year":"2004","unstructured":"Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkotter J, Piomelli D (2004) Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 29:2108\u20132114","journal-title":"Neuropsychopharmacology"},{"key":"789_CR28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","volume":"41","author":"MN Hill","year":"2008","unstructured":"Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ (2008) Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 41:48\u201353","journal-title":"Pharmacopsychiatry"},{"key":"789_CR29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","volume":"34","author":"MN Hill","year":"2009","unstructured":"Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ (2009) Circulating endocannabinoids and n-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34:1257\u20131262","journal-title":"Psychoneuroendocrinology"},{"key":"789_CR30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.mp.4001376","volume":"9","author":"BL Hungund","year":"2004","unstructured":"Hungund BL, Vinod KY, Kassir SA, Basavarajappa BS, Yalamanchili R, Cooper TB, Mann JJ, Arango V (2004) Upregulation of CB1 receptors and agonist-stimulated [35s]gtpgammas binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 9:184\u2013190","journal-title":"Mol Psychiatry"},{"key":"789_CR31","doi-asserted-by":"crossref","first-page":"e69869","DOI":"10.1371\/journal.pone.0069869","volume":"8","author":"D Inta","year":"2013","unstructured":"Inta D, Lima-Ojeda JM, Lau T, Tang W, Dormann C, Sprengel R, Schloss P, Sartorius A, Meyer-Lindenberg A, Gass P (2013) Electroconvulsive therapy induces neurogenesis in frontal rat brain areas. PLoS One 8:e69869","journal-title":"PLoS One"},{"key":"789_CR32","doi-asserted-by":"crossref","first-page":"723915","DOI":"10.1155\/2014\/723915","volume":"2014","author":"P Rotheneichner","year":"2014","unstructured":"Rotheneichner P, Lange S, O\u2019Sullivan A, Marschallinger J, Zaunmair P, Geretsegger C, Aigner L, Couillard-Despres S (2014) Hippocampal neurogenesis and antidepressive therapy: shocking relations. Neural Plast 2014:723915","journal-title":"Neural Plast"},{"key":"789_CR33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1224162","volume":"42","author":"A Sartorius","year":"2009","unstructured":"Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, Danker-Hopfe H, Gass P (2009) Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42:270\u2013276","journal-title":"Pharmacopsychiatry"},{"key":"789_CR34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/mp.2012.93","volume":"18","author":"R Lanzenberger","year":"2013","unstructured":"Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R (2013) Global decrease of serotonin-1a receptor binding after electroconvulsive therapy in major depression measured by pet. Mol Psychiatry 18:93\u2013100","journal-title":"Mol Psychiatry"},{"key":"789_CR35","first-page":"94","volume":"4","author":"R Fosse","year":"2013","unstructured":"Fosse R, Read J (2013) Electroconvulsive treatment: Hypotheses about mechanisms of action. Front Psychiatry (Frontiers Research Foundation) 4:94","journal-title":"Front Psychiatry (Frontiers Research Foundation)"},{"key":"789_CR36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00406-013-0420-5","volume":"264","author":"C Hoyer","year":"2014","unstructured":"Hoyer C, Kranaster L, Janke C, Sartorius A (2014) Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci 264:255\u2013261","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"789_CR37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00406-011-0205-7","volume":"261","author":"L Kranaster","year":"2011","unstructured":"Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A (2011) Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci 261:575\u2013582","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"789_CR38","volume-title":"The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (a task force report of the american psychiatric association)","author":"American Psychiatric Association","year":"2001","unstructured":"American Psychiatric Association (2001) The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (a task force report of the american psychiatric association). American Psychiatric Association, Washington"},{"key":"789_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-4939-3539-0_2","volume":"1412","author":"L Bindila","year":"2016","unstructured":"Bindila L, Lutz B (2016) Extraction and simultaneous quantification of endocannabinoids and endocannabinoid-like lipids in biological tissues. Methods Mol Biol 1412:9\u201318","journal-title":"Methods Mol Biol"},{"key":"789_CR40","doi-asserted-by":"crossref","first-page":"18150","DOI":"10.1073\/pnas.1113444108","volume":"108","author":"E Sigel","year":"2011","unstructured":"Sigel E, Baur R, Racz I, Marazzi J, Smart TG, Zimmer A, Gertsch J (2011) The major central endocannabinoid directly acts at gaba(a) receptors. Proc Natl Acad Sci USA 108:18150\u201318155","journal-title":"Proc Natl Acad Sci USA"},{"key":"789_CR41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(03)00145-3","volume":"119","author":"M Egertova","year":"2003","unstructured":"Egertova M, Cravatt BF, Elphick MR (2003) Comparative analysis of fatty acid amide hydrolase and CB(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119:481\u2013496","journal-title":"Neuroscience"},{"key":"789_CR42","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00213-015-4105-9","volume":"233","author":"E Boorman","year":"2016","unstructured":"Boorman E, Zajkowska Z, Ahmed R, Pariante CM, Zunszain PA (2016) Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression? Psychopharmacology (Berl) 233:1591\u20131604","journal-title":"Psychopharmacology (Berl)"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-017-0789-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-017-0789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-017-0789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T05:24:01Z","timestamp":1509341041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-017-0789-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1007\/s00406-017-0789-7","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]}}}